Tealwood Asset Management Inc Halozyme Therapeutics, Inc. Transaction History

Tealwood Asset Management Inc

$228 Million
Q3 2024

A detailed history of Tealwood Asset Management Inc transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Tealwood Asset Management Inc holds 44,119 shares of HALO stock, worth $1.88 Million. This represents 1.11% of its overall portfolio holdings.

Number of Shares

44,119

Previous 44,301 0.41%

Holding current value

$1.88 Million

Previous $2.32 Million 8.84%

% of portfolio

1.11%

Previous 1.4%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$51.3 - $64.42 $9,336 - $11,724	-182 Reduced 0.41%	44,119 $2.53 Million
Q2 2024 Jul 09, 2024	SELL	$37.81 - $52.4 $8,885 - $12,314	-235 Reduced 0.53%	44,301 $2.32 Million
Q1 2024 Apr 11, 2024	SELL	$33.68 - $41.95 $2,930 - $3,649	-87 Reduced 0.19%	44,536 $1.81 Million
Q4 2023 Jan 08, 2024	SELL	$33.32 - $42.1 $39,417 - $49,804	-1,183 Reduced 2.58%	44,623 $1.65 Million
Q3 2023 Nov 08, 2023	SELL	$36.46 - $44.03 $32,048 - $38,702	-879 Reduced 1.88%	45,806 $1.75 Million
Q2 2023 Jul 26, 2023	SELL	$30.28 - $38.74 $14,655 - $18,750	-484 Reduced 1.03%	46,685 $1.68 Million
Q1 2023 Apr 12, 2023	BUY	$32.86 - $55.7 $687,431 - $1.17 Million	20,920 Added 79.7%	47,169 $1.8 Million
Q4 2022 Jan 17, 2023	SELL	$40.06 - $59.44 $93,139 - $138,198	-2,325 Reduced 8.14%	26,249 $1.49 Million
Q3 2022 Nov 16, 2022	BUY	$38.53 - $51.78 $2,388 - $3,210	62 Added 0.22%	28,574 $1.13 Million
Q2 2022 Jul 20, 2022	SELL	$37.35 - $48.3 $33,988 - $43,953	-910 Reduced 3.09%	28,512 $1.26 Million
Q1 2022 May 02, 2022	SELL	$31.97 - $41.06 $16,784 - $21,556	-525 Reduced 1.75%	29,422 $1.17 Million
Q4 2021 Mar 15, 2022	SELL	$31.82 - $40.75 $12,823 - $16,422	-403 Reduced 1.33%	29,947 $1.2 Million
Q3 2021 Dec 02, 2021	SELL	$38.47 - $46.42 $117,756 - $142,091	-3,061 Reduced 9.16%	30,350 $1.24 Million
Q1 2021 Jun 21, 2021	BUY	$39.51 - $51.45 $7,032 - $9,158	178 Added 0.54%	33,411 $1.39 Million
Q4 2020 Mar 09, 2021	BUY	$25.81 - $43.62 $857,743 - $1.45 Million	33,233 New	33,233 $1.42 Million

Others Institutions Holding HALO

# of Institutions

542

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $5.93B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tealwood Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tealwood Asset Management Inc with notifications on news.

Account

Tealwood Asset Management Inc Halozyme Therapeutics, Inc. Transaction History